The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.

The Anti-Kickback Statute prohibits anyone from offering or paying, directly or indirectly, money or anything else of value ...

CVS Health (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The ...

With the flu season imminent, new COVID-19 and influenza vaccines are available. What’s new with the vaccines and when should ...

The American Lung Association and the CVS Health Foundation announced today a new, comprehensive project to significantly bolster the efforts of health care providers and organizations nationwide to ...

XRP Healthcare is taking bold steps to become a leader in the integration of artificial intelligence (AI) and blockchain ...

CVS Health announced the updated 2024-2025 COVID-19 vaccines and flu vaccines are available at pharmacy and MinuteClinic locations. WOONSOCKET – CVS Health Corp. announced the updated 2024-2025 ...

raising the risk of heart health issues. “In general, chronic elevations of blood pressure are a risk factor for future cardiovascular disease such as heart attack, heart failure, or stroke ...

In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against the other beaten down dividend stocks. Dividend stocks have faced challenges over the past ...

Wells Fargo analyst Steve Baxter maintained a Hold rating on CVS Health (CVS – Research Report) yesterday and set a price target of $61.00. The company’s shares closed last Friday at $57.24.